Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil in STEMI Patients Undergoing PCI (CHANGE 001)
NCT03445728Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicorandil in ST-segment elevation myocardial infarction (STEMI), sponsored by Chinese PLA General Hospital. Started Feb 2018; status: completed.
02
Drugs
nicorandil
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03445728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445728.